It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Utilising one-carbon substrates such as carbon dioxide, methane, and methanol is vital to address the current climate crisis. Methylotrophic metabolism enables growth and energy generation from methanol, providing an alternative to sugar fermentation. Saccharomyces cerevisiae is an important industrial microorganism for which growth on one-carbon substrates would be relevant. However, its ability to metabolize methanol has been poorly characterised. Here, using adaptive laboratory evolution and 13C-tracer analysis, we discover that S. cerevisiae has a native capacity for methylotrophy. A systems biology approach reveals that global rearrangements in central carbon metabolism fluxes, gene expression changes, and a truncation of the uncharacterized transcriptional regulator Ygr067cp supports improved methylotrophy in laboratory evolved S. cerevisiae. This research paves the way for further biotechnological development and fundamental understanding of methylotrophy in the preeminent eukaryotic model organism and industrial workhorse, S. cerevisiae.
Methylotrophic metabolism enables growth on methanol, an alternative to sugar fermentation. Here the authors use adaptive laboratory evolution to uncover native methylotrophy capacity in Saccharomyces cerevisiae.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Macquarie University, Department of Molecular Sciences, ARC Centre of Excellence in Synthetic Biology, North Ryde, Australia (GRID:grid.1004.5) (ISNI:0000 0001 2158 5405); CSIRO Synthetic Biology Future Science Platform, Canberra, Australia (GRID:grid.1016.6)
2 The University of Queensland, Australian Institute for Bioengineering and Nanotechnology, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
3 The University of Queensland, Australian Institute for Bioengineering and Nanotechnology, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); Institute of Technology, University of Tartu, ERA Chair in Gas Fermentation Technologies, Tartu, Estonia (GRID:grid.10939.32) (ISNI:0000 0001 0943 7661)
4 The University of Queensland, Australian Institute for Bioengineering and Nanotechnology, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); The University of Queensland, Queensland Node of Metabolomics Australia, AIBN, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
5 CSIRO Synthetic Biology Future Science Platform, Canberra, Australia (GRID:grid.1016.6); Biocatalysis and Synthetic Biology Team, CSIRO Land & Water, Black Mountain Science and Innovation Park, Canberra, Australia (GRID:grid.469914.7)
6 Macquarie University, Department of Molecular Sciences, ARC Centre of Excellence in Synthetic Biology, North Ryde, Australia (GRID:grid.1004.5) (ISNI:0000 0001 2158 5405)